endopromag
Advertisement
  • Home
  • News
  • Magazine
    • Current Issue
    • Past Issues
  • Online Content
    • Articles
    • References
    • Education
    • Products
    • Videos
  • Subscribe
  • About us
  • Contact us
No Result
View All Result
endopromag
No Result
View All Result
Home Escherichia coli

Scientists discover how ‘superbug’ E. coli clones take over human gut

endopromag_adn by endopromag_adn
October 6, 2023
in Escherichia coli, Healthcare
0
Scientists discover how ‘superbug’ E. coli clones take over human gut
74
SHARES
1.2k
VIEWS
Share on FacebookShare on Twitter
A “superbug” clone of E. coli has evolved to prevent itself from becoming so dominant that it could potentially wipe out the bacteria from existence, scientists led by the University of Birmingham have discovered. The researchers investigated how and why a clone of E. coli called ST131 has become the major cause of drug-resistant E. coli infections, but not so dominant that it has wiped out other clones that do not have multidrug resistance. Escherichia coli (E. coli) is a type of bacteria common in human and animal intestines, and forms part of the normal gut flora, the bacteria that exist in the bowel. There are a number of different types of E. coli and, while the majority are harmless, some can cause serious food poisoning or infections including in the urinary tract or bloodstream. The number of cases of E. coli have risen by 27% from 32,309 in 2012-13 to 41,060 in 2017-18. The rise has been linked to an increase in antibiotic resistant infections caused by so-called “superbugs.” “The most globally dominant clone of E. coli that is resistant to multiple drugs is called ST131,” said Alan McNally, PhD, of the University of Birmingham’s Institute of Microbiology and Infection. “Earlier research has shown that while ST131 emerged and rapidly spread in the late 1990s, it caused no more than 20% of clinical cases of E. coli once it had emerged on the scene.” He continued, “Following our research, we now know that while there are significantly dominant drug resistant clones of E. coli such as ST131 and other new ones are emerging all the time, it seems highly unlikely that any of them are ever going to become a completely dominant clone because this process called NFDS controls the balance across the whole E. colipopulation.” Professor Jukka Corander, of the Wellcome Sanger Institute in Cambridge, the University of Oslo in Norway, and the University of Helsinki in Finland, said that as part of the research the scientists also analyzed almost 1,000 genome sequences of strains within ST131 to see if they could find any genetic patterns that may explain how this process happens. “We found that in the ST131 clone there was a lot of variation in the genes that are involved in allowing the bacteria to colonize in the human gut when compared to those in non-drug resistant bacteria that are very closely related to ST131,” he said. “If a person is going to get a bloodstream or urinary infection from E. coli it usually comes after it has colonized in the gut, therefore we now know that genetically something has happened to this superbug which allows it to colonise the gut far more competitively than other E. coli.” He continued, “If we can understand why a multi-drug resistant E. coli out competes our resident healthy E.coli in the gut, we can try and find ways to prevent this from happening. This now needs to be the focus of further research.” The research, published in mBio, was also carried out in collaboration with the British Society of Antimicrobial Chemotherapy, the Wellcome Trust Sanger Institute, the London School of Hygiene and Tropical Medicine, and Imperial College London. Source: University of Birmingham
Tags: News
Share30Tweet19

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Browse by Category

ADVERTISEMENT

Related News

Gut bacteria byproduct protects against Salmonella

Gut bacteria byproduct protects against Salmonella

October 8, 2023
Researchers identify seasonal peaks for foodborne infections

Researchers identify seasonal peaks for foodborne infections

October 5, 2023
Bradley Catalone Joins Healthmark Industries

Bradley Catalone Joins Healthmark Industries

October 6, 2023

Tags

AAMI AORN Award Bacteria BIOCHEMISTRY biology cancer CBSPD Chemotherapy colon cancer colorectal cancer colorectal cancer screening COVID-19 CRC Digestive Health Duodenoscope Education EndoPro Magazine Endoscope Endoscopy FDA gastroenterology gastrointestinal disorders Genetics GI Healthcare Healthmark IAHCSMM IBD IBS Infections Internal medicine irritable bowel syndrome Medicine MEDICINE/HEALTH Microbiology News Nursing polyps PPE Public Health recall Screening SGNA Studies
endopromag

EndoPro Magazine is the award winning advocate for today’s endoscopy profession. We are the go-to source for endoscopy nurses, technicians, and their colleagues in hospitals, ambulatory care centers, and free-standing endoscopy facilities in the United States and abroad.

Browse by Topic

Anal CancerAntibiotic Resistance

C. diffCancerCentral Services

ColitisDiet/Body WeightEquipment

ERCPGastroenterologyView All

Current Issue

CURRENT ISSUE CURRENT ISSUE CURRENT ISSUE

© 2023 Copyright. All Rights Reserved. Design & Developed by Insightful Technologies.

No Result
View All Result
  • Home
  • News
  • Magazine
    • Current Issue
    • Past Issues
  • Online Content
    • Articles
    • References
    • Education
    • Products
    • Videos
  • Subscribe
  • About us
  • Contact us

© 2023 Copyright. All Rights Reserved. Design & Developed by Insightful Technologies.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?
Go to mobile version